Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.

ABSTRACT:

Background

Lianhua Qingwen Granules or Capsules (LHQW) has accumulated much research evidence in the fight against the coronavirus disease 2019 (COVID-19) epidemic. However, there are still few data on its efficacy and safety in children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Purpose

To evaluate the efficacy and safety of LHQW in children with SARS-CoV-2 Omicron infection.

Methods

We conducted a single-center, propensity-score matched retrospective cohort study of children with SARS-CoV-2 Omicron infection in Shanghai New International Expo Center mobile cabin hospital between April 1st and June 1st, 2022. Eligible patients received either LHQW granules/capsules plus supportive care (LHQW group) or supportive care alone (control g

SUBMITTER: Xu X 

PROVIDER: S-EPMC9831666 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature